Express Scripts (NASDAQ:ESRX) Post Higher Profit in Fiscal Fourth Quarter on Medco Health Acquisition

Express Scripts Holding Company (NASDAQ:ESRX) reported on Monday that its profit in fiscal Q4 moved up 74% from previous year, as revenue hiked assisted by purchase of competitor Medco health Solutions Inc in April 2012.

Pharmacy benefits manager’s quarterly EPS also came in above analysts’ forecasts. Simultaneously, the corporation offered positive earnings guidance for the current year.

The St Louis, Missouri based Express Scripts Holding announced net income of $504.1 million or $0.61 a share for fiscal Q4 finished December 31, 2012, evaluated against $290.4 million or $0.59 a share for the same period previous year.

Thomson Reuters 21 analysts survey on average forecasted to announce earnings of $1.04 a share for fiscal fourth quarter.

Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Catamaran Corp (USA) (NASDAQ:CTRX) rose +1.04% to settle at $53.65, AmerisourceBergen Corp. (NYSE:ABC) moved down -0.36% to end at $46.60 while UnitedHealth Group Inc. (NYSE:UNH) jumped +0.47% to finish at $57.32 on Friday.

Express Scripts Holding Company (NASDAQ:ESRX) last session’s volume of 9.79 million shares was higher than its average volume of 5.42 million shares. The stock after opening at $55.17 hit high price of $55.60 and then closed at $55.57 by scoring +0.85%.

ESRX generated revenue of $78.93 billion in the previous twelve months and earned $1.10 billion. The Company showed a positive 1.39% in the net profit margin as well as in its operating margin which remained at 3.08%. Company’s annual sales growth for the past five years was 16.43%.

The ESRX’s past twelve months’ price to sales ratio was 0.57 and price to cash ratio remained 36.34. As far as the returns are concerned, ESRX’s return on equity was recorded as 8.83% and return on investment increased 4.29% while its return on asset stayed at 3.22%.

The stock showed weekly downbeat performance of -0.30% which was maintained for the month at 2.17%. Likewise the positive performance for the quarter was recorded as 11.03% and for the year was 6.62% while the YTD performance remained at 2.91%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Main Post and tagged , , , , , , , , , , , . Bookmark the permalink.